BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2012
View Archived Issues
Phase I and II data presented for semaglutide
Read More
Zalypsis ineffective in urothelial carcinoma
Read More
Genentech begins phase II trials of ADCs based on Seattle Genetics technology
Read More
Preliminary results given for TH-302 with bevacizumab in glioblastoma
Read More
In vitro, in vivo and phase I data on DS-8587 presented
Read More
Synageva BioPharma patents novel polypeptides
Read More
City of Hope discloses new siRNA systems for HIV
Read More
Researchers at Takeda Pharmaceutical design novel PDE10A inhibitors
Read More
Significant reduction of HbA1c seen with VRS-859 in clinical trial
Read More
New GCS activators synthesized by Boehringer Ingelheim
Read More
New LTA mimetics divulged by scientists in Germany and The Netherlands
Read More
Zafgen presents novel MetAP 2 inhibitors for obesity
Read More
Novavax begins phase II RSV vaccine study in women of childbearing age
Read More
Enrollment continues in Can-Fite BioPharma's phase II/III psoriasis study
Read More
U.K. authorities clear phase I malaria vaccine trial with Isconova's adjuvant Matrix-M
Read More
Aeras and GSK enter agreement on tuberculosis vaccine development
Read More
Phase I ACP-501 study meets primary endpoint in stable atherosclerosis
Read More
New NICE guidance on Crohn's disease released
Read More
Crucell signs agreement to use Mucosis' platform for vaccine program
Read More
Researchers find possible biomarker for renal cell carcinoma
Read More
MedGenesis obtains new grant to develop glial cell line product
Read More
Oxford BioMedica provides update on TroVax development
Read More
Merck & Co. plans to initiate North American HDM AIT study
Read More
Canadian commercialization agreement set for MoxDuo
Read More
Cleveland BioLabs and Incuron announce start of phase I trial of CBLC-137
Read More
Navidea provides update on Lymphoseek NDA
Read More
FDA grants QIDP designation to radezolid
Read More